| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.7 | 0.005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |